Related Experiment Video
Updated: May 24, 2026
07:08
Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
Published on: February 2, 2024
Locally advanced pancreatic adenocarcinoma: update and progress
John Ng1, Chi Zhang, Daniela Gidea-Addeo
1Columbia University College of Physicians and Surgeons, New York Presbyterian Hospital, New York, NY 10032, USA.
JOP : Journal of the Pancreas
|March 13, 2012
Summary
Novel treatments for locally advanced pancreatic cancer show promise. New approaches include surgery for recurrent disease, chemoradiation, and the FOLFIRINOX regimen, offering hope for this challenging cancer.
Area of Science:
- Oncology
- Gastrointestinal Cancers
Background:
- Pancreatic cancer is a leading cause of cancer death in the U.S.
- Surgical resection offers cure in less than 20% of cases.
- Locally advanced pancreatic cancer has seen limited treatment advances.
Purpose of the Study:
- To highlight novel approaches for treating locally advanced pancreatic cancer presented at the ASCO Gastrointestinal Cancers Symposium.
- To discuss advancements in surgical and chemoradiation strategies.
- To review the application of multi-agent chemotherapy regimens.
Main Methods:
- Presentation of three abstracts (#252, #254, #313) at the ASCO Gastrointestinal Cancers Symposium.
- Discussion of surgical interventions for recurrent disease.
- Evaluation of a new chemoradiation regimen.
- Review of the FOLFIRINOX regimen (oxaliplatin, irinotecan, leucovorin, 5-fluorouracil) in a non-clinical trial setting.
Main Results:
- Novel approaches presented offer potential advancements in managing locally advanced pancreatic cancer.
- Surgery for recurrent disease shows promise.
- A new chemoradiation regimen is identified as promising.
- The FOLFIRINOX regimen is being applied in non-clinical trial settings.
Conclusions:
- Recent advancements presented at the ASCO Gastrointestinal Cancers Symposium offer new hope for treating locally advanced pancreatic cancer.
- Multi-agent chemotherapy, including FOLFIRINOX, and improved surgical and chemoradiation techniques are key areas of focus.
- These novel approaches aim to improve outcomes for patients with difficult-to-treat pancreatic cancer.
